Hormones, cytokines and fetal anomalies in habitual abortion

Gynecological Endocrinology

Volumn 15, Issue 6, 2001, Pages 472-483

  Carp, H ^a,b   Torchinsky, A ^b   Fein, A ^b   Toder, V ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cytokines; Fetal Anomalies; Habitual Abortion; HCG; Pregnancy Loss; Progesterone; Recurrent Miscarriage

Indexed keywords

ANDROSTANOLONE; CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; CYTOKINE; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HORMONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHOLIPID ANTIBODY; PROGESTERONE; RELAXIN; STEROID HORMONE; TERATOGENIC AGENT; TESTOSTERONE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BIRTH RATE; BLASTOCYST; CHROMOSOME ABERRATION; EARLY DIAGNOSIS; ECHOGRAPHY; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FETUS DEATH; FETUS KARYOTYPING; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOMODULATION; IMMUNOPOTENTIATION; NONHUMAN; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PRIORITY JOURNAL; RECURRENT ABORTION; REVIEW; TH1 CELL; TH2 CELL; UTERUS MALFORMATION;

EID: 0035702134     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.15.6.472.483     Document Type: Review

References (108)

1. Recurrent spontaneous abortions
2. An informative protocol for the investigation of recurrent miscarriage; preliminary experience of 500 consecutive cases
3. Pitfalls in interpreting therapy for early pregnancy
4. The epidemiology of human spontaneous abortions with chromosomal anomalies
5. Early fetal loss
6. Embryonic karyotype of abortuses in relation to the number of previous miscarriages
7. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion
8. Karyotype of the abortus in recurrent miscarriage
9. Royal College of Obstetricians and Gynaecologists
10. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies
11. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3)
12. Sera from women with histories of repeated pregnancy losses cause abnormalities in mouse perimplantation blastocysts
13. In vitro suppression of murine blastocysts growth by sera from women with reproductive disorders
14. Immunopotentiation reverses the embryotoxic effect of serum from women with pregnancy loss
15. The effects of sera from women with spontaneous abortions on the in vitro development of early somite stage rat embryos
16. Early pregnancy loss: Current concepts of research and treatment
17. Yolk sac diameter and shape at endovaginal US: Predictors of pregnancy outcome in the first trimester
18. 1 and risk for major malformation and spontaneous abortion in diabetic pregnancy
19. Multifactorial basis of the syndrome of diabetic embryopathy
20. MHC associated immunopotentiation affects the embryo response to teratogens
21. Suppression of developmental anomalies by maternal macrophages in mice
22. Role of a unique species of TGF-β in preventing rejection of the conceptus during pregnancy
23. Role of lymphokines of the CSF family and of TNF, gamma interferon and IL-2 in placental growth and fetal survival studied in two murine models of spontaneous resorptions
24. Stress-induced murine abortion associated with substance P-dependent alteration in cytokines in maternal uterine decidua
25. The cytokine basis for cross-talk between the maternal immune and reproductive systems
26. Functions of human decidual NK cells
27. Immunological prevention of spontaneous early embryo resorption is mediated by non specific immunostimulation
28. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblast
29. Lipopolysaccharide-induced fetal resorption in mice is associated with the intrauterine production of tumor necrosis factor-alpha
30. Tumor necrosis factor-α in midtrimester amnniotic fluid is associated with impaired intrauterine fetal growth
31. Soluble receptors neutralizing TNF-α and IL-1 block stress-triggered murine abortion
32. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor alpha in the rabbit
33. Growth factor regulation of cell cycle progression and cell fate determination
34. Growth factors and mitogen-activated protein kinases
35. Cell death
36. Cellular responses to stress
37. Cyclophosphamide teratogenesis: A review
38. Cell cycle control and cancer
39. Cell death by apoptosis and its protective role against disease
40. Developmental expression and CORT-regulation of TGF-β and EGF receptor mRNA during mouse palatal morphogenesis: Correlation between CORT-induced cleft palate and TGF-β2 mRNA expression
41. Cyclophosphamide-induced teratogenesis in ICR mice: The role of apoptosis
42. TNF-α expression in embryos exposed to a teratogen
43. A possible role for granulocyte - Macrophage colony stimulating factor in modulating teratogen-induced effects
44. Reactive intermediates
45. Regulation of cytochromes P450 during inflammation and infection
46. Vaccination against spontaneous abortion in mice
47. The emerging role of IL-10 in pregnancy
48. Hyperthermia and birth defects
49. Maternal immunopotentiation affects the teratogenic response to hypothermia
50. Is stress a developmental toxin?
51. Stress-triggered abortion in mice is prevented by alloimmunization
52. Immunopotentiation increases the resistance of mouse embryos to diabetes induced teratogenic effect
53. Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters
54. Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion
55. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion
56. Worldwide collaborative observational study and metaanalysis on allogenic leucocyte immunotherapy for recurrent spontaneous abortion
57. Paternal leucocyte immunization after five or more miscarriages
58. Mononuclear-cell immunisation in prevention of recurrent miscarriages: A randomised trial
59. Immunization with refrigerated paternal cells did not prevent recurrent miscarriage
60. Immunotherapy for recurrent spontaneous abortion
61. Intravenous immunoglobulin in women with five or more abortions
62. The effectiveness of allogeneic leucocyte immunization in unexplained primary recurrent spontaneous abortion
63. Further experience with intravenous immunoglobulin in women with recurrent miscarriage and a poor prognosis
64. Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones
65. Adrenal hormone modulation of type 1 and 2 cytokine production by spleen cells: Dexamethasone and dehydroepiandrosterone suppress interleukin-2, interleukin-4 and interferon-gamma production in vitro
66. Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells
67. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance
68. Regulation of IL-3 expression by glucocorticoids in cloned murine T-lymphocytes
69. Differential regulation of interleukin 10 (IL10) and IL-12 by glucocorticoids in vitro
70. Corticosteroid modulation of human antigen-specific Th1 and Th2 responses
71. Biotinylated anti-progesterone monoclonal antibodies specifically target the uterine epithelium and block implantation in the mouse
72. Immunoregulatory role of the placenta
73. Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy
74. Allergen and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production
75. Reciprocal regulatory role of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 cells
76. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established ThI cells clones
77. Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl2 expression
78. Relaxin
79. Relaxin favors the development of activated human T cells into Th1-like effectors
80. Effect of estradiol on interleukin-1 synthesis by macrophages
81. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity
82. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from post-menopausal women
83. Demonstration of functional cytokine - Placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion
84. The regulation of progesterone and hCG production from placental cells by interleukin-1beta
85. The effects of cytokines on human chorionic gonadotropin (hCG) production by a trophoblast cell line
86. Soluble IL-6 (IL-6) receptor in the sera of pregnant women forms a complex with IL6 and augments human chorionic gonadotropin production by normal human trophoblast through binding to the IL-6 signal transducer
87. Modulation of the baboon (Papio anubis) endometrium by chorionic gonadotropin (CG) during the period of uterine receptivity
88. Chorionic gonadotropin-beta mRNA, a trophoblast marker, is expressed in human 8-cell embryos derived from tripronucleate zygotes
89. Up-regulation of cyclooxygenase-2 gene expression by chronic gonadotropin during the differentiation of human endometrial stromal cells into decidua
90. Stimulation of cyclic AMP, 17β oestradiol and protein synthesis by human chorionic gonadotropin in human endometrial cells
91. Effect of human chorionic gonadotropin on cytokine production from human endometrial cells in vitro
92. Human chorionic gonadotropin (hCG) and placental lactogen (hPL) inhibit interleukin-2 and increase interleukin-1β (IL-1β) -6 (IL-6) and tumor necrosis factor (TNFα) expression monocyte cultures
93. The luteal phase defect
94. Indispensability of the human corpus luteum in the maintenance of early pregnancy: Lutectomy evidence
95. Early pregnancy termination with mifepristone and misoprostol in the United States
96. Dehydrogestone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency
97. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: A double-blind clinical trial
98. The primary treatment of luteal phase inadequacy: Progesterone versus clomiphene citrate
99. Oral clomiphene citrate and vaginal progesterone suppositories in the treatment of luteal phase dysfunction: A comparative study
100. Outcome of progesterone treatment of luteal phase inadequacy
101. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials
102. The use of human chorionic gonadotropin in recurrent abortion
103. Preliminary experience with the use of human chorionic gonadotrophin therapy in women with repeated abortion
104. Treatment of habitual abortion with human chorionic gonadotropin: Results of open and placebo-controlled studies
105. Human chorionic gonadotrophin (hCG) in the management of recurrent abortion; results of a multi-centre placebo-controlled study
106. Human chorionic gonadotropin supplementation in recurring pregnancy loss: A controlled trial
107. Heart rate as a predictor of first trimester spontaneous abortion after ultrasound proven viability